Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.

Project description

A test bed for assessing nanotechnology-based medical devices

Nanotechnology is increasingly being utilised for the development of medical devices. As with all technological innovations that find applications in the healthcare sector, there is a need for careful assessment of potential risks and benefits. The EU-funded SAFE-N-MEDTECH project will develop an open access platform to provide the knowhow, networks and services required for the development of nanotechnology-based medical and diagnostic devices. The SAFE-N-MEDTECH platform will be directed to companies and laboratories and offer an integrated approach for assessing qualification, regulation, biocompatibility and the properties of nanomaterials. Implementation of the platform will expedite the transition of nanotechnology-based medical technologies to the market.

Objective

Society and clinical practice pose a growing demand on novel biomaterials, ICT, micro and nanotechnologies for innovative medical devices and in vitro diagnostics (Medical Technologies-MTs). In addition to the challenge of time, the new technologies are subjected to other pressing factors such as qualification, regulation, cost, biocompatibility and the need to be applicable worldwide. In the most recent years it is obvious that nano-enabled MTs can be applied in nearly every medical area, with a major presence and increased importance in cancer, regenerative medicine, advanced therapies, neurology, cardiology, orthopaedics, and dentistry. On the other hand, any innovation in the Health sector has to be carefully assessed in terms of risk/benefit ratio. Nano-enabled MTs particularly require careful assessment, since they are complex products group and their technological assessments are still under development. This assessment will be a key pillar for the here proposed Open Innovation Test Bed (OITB)
To address all the aforementioned challenges, the SAFE-N-MEDTECH consortium aims to bring a strong and competitive cooperation to compete in the market for a coordinated OITB for nano-enabled MTs. SAFE-N-MEDTECH will build an innovative open access platform to offer to companies and reference laboratories, the capabilities, knowhow, networks and services required for the development, testing, assessment, upscaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices. This across the whole Life Cycle. This OITB will offer a multidisciplinary and market oriented innovation approach to SME´s, Healthcare providers and Industries for the translation to the market of MTs, based on a deep understanding and knowledge of the material-nanoproperties, their advance use and applications in MTs and other aspects involved in MTs safety (electric compatibility, electromagnetic properties, etc).

Call for proposal

H2020-NMBP-TO-IND-2018-2020

See other projects for this call

Sub call

H2020-NMBP-HUBS-2018

Coordinator

FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS
Net EU contribution
€ 157 556,31
Address
RONDA DE AZKUE,1
48902 Barakaldo
Spain

See on map

Region
Noreste País Vasco Bizkaia
Activity type
Research Organisations
Links
Total cost
€ 157 556,31

Participants (36)